Mary Ann Stevenson, MD

Beth Israel Deaconess Medical Center

Boston, Massachusetts - 02215

CLINICAL TRIALS 1
CONDITIONS13
INTERVENTIONS2
SINCE2008

Reduced Intensity Conditioning With Clofarabine Antithymocyte Globulin (ATG) Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant

June 2008 - June 2011

Lymphoma

Lymphoma, Non-Hodgkin

Multiple Myeloma

Neoplasms, Plasma Cell

Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell

Leukemia, Lymphoid

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Leukemia, Myeloid, Acute

Leukemia, Myeloid

Myelodysplastic Syndromes

Preleukemia

Hodgkin Disease

Clofarabine

Antithymocyte Globulin

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Mary Ann Stevenson, MD

Beth Israel Deaconess Medical Center

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP